Applied Biosystems and Geospiza Team Up to Offer Next-Generation Genetic Analysis on Amazon Web Services
CARLSBAD, Calif.–(BUSINESS WIRE)–Applied Biosystems, a division of Life Technologies Corporation (NASDAQ:LIFE), and Geospiza, Inc. today announced the launch of a next-generation genetic analysis solution to meet the computational infrastructure and analysis challenges of customers using advanced genomic analysis platforms. The organizations are combining forces to offer the life-science industry’s first jointly offered genomic analysis cloud-computing solution, which is an approach to computing in which dynamically scalable and often virtual resources are provided as a service over the Internet. This offering leverages the web-scale infrastructure from Amazon Web Services.
A solution of this nature is significant because a great number of scientists using next-generation sequencing platforms face significant challenges with the vast amounts of sequencing data generated by these systems, requiring many hours and computing resources to manage, distribute and analyze the data. This solution solves many of these challenges by allowing scientists to easily transfer their data to the data center, manage and store their data, as well as access bioinformatic software tools to analyze their data.
The combination of Amazon Web Services and Geospiza will enable scientists using the SOLiD System, Applied Biosystems’ platform for next-generation genomic analysis, to access the most current analysis technologies in real time. Using the massive processing capacity of Amazon Web Services, scientists using the SOLiD System will be able to access the Applied Biosystems mapping tool for sequencing reads that is offered with Geospiza’s industry-leading genetic analysis software, GeneSifter®. Geospiza, a member of the Applied Biosystems SOLiD Software Development Community, is the first commercial provider to include this software as part of its analysis system. The combination of these industry leaders offers customers a rapid way to analyze their genetic data accurately, rapidly, and at lower cost.
Kip Miller, President of Life Technologies’ Genetic Systems Division
“The solution we’ve created in partnership with Geospiza on top of the Amazon Web Services platform is a strategic initiative to ensure that scientists in the life science industry have web-based, affordable access to the advanced genomic analysis tools they need to be successful with the SOLiD technology. Taking significant steps to advance the bioinformatics structure to support next-generation sequencing will accelerate its use and unlock the full potential of this technology to bring about the era of personalized medicine.”
Steve Rabuchin, Director of Business Development and Developer Relations, Amazon Web Services
“Amazon Web Services has been working to deliver powerful, cost-effective web infrastructure solutions to speed innovation and discovery. Deploying GeneSifter next-generation genetic analysis for SOLiD on Amazon Web Services extends the power of the AWS platform to an important community of scientists who are interested in advancing medical research.”
Rob Arnold, President, Geospiza
“We are constantly looking for new ways to innovate and expand offerings and services to our customers. Our products have been available through the cloud computing model for more than five years and are optimized for this type of architecture. We are excited to have the opportunity to work with Amazon and Life Technologies to offer virtually limitless scale and computing power to our customers at an affordable price through this initiative with Applied Biosystems and Amazon.”
For more information about Next Generation Genetic Analysis in the Cloud or to get more information about the combined Applied Biosystems/Geospiza offering, please visit http://www.geospiza.com/Cloud/.
Supporting Resources
Applied Biosystems Leadership in Advanced Genomics
Applied Biosystems is a global leader in providing innovative instrument systems to accelerate academic and clinical research, drug discovery and development, pathogen detection and forensic DNA analysis. It is a leader in the development of advanced genomic technologies that include a robust line of DNA sequencing systems and chemistries to meet the increasing demands of the scientific community for higher throughput, more sophisticated DNA sequencing solutions. Applied Biosystems, together, with Invitrogen – a leading provider of platform independent, essential life science technologies for disease and drug research, bioproduction and diagnostics – is part of Life Technologies Corporation, which markets the life science industry’s most comprehensive portfolio of solutions for molecular and cell biology. Applied Biosystems and Invitrogen products are used in nearly every major laboratory in the world. For more information, please visit: www.appliedbiosystems.com and www.invitrogen.com.
About Life Technologies
Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of more than $3 billion in 2008, employs approximately 9,500 people, has a presence in more than 100 countries, and possesses a rapidly growing intellectual property estate of approximately 3,600 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc. For more information on how we are making a difference please visit our website: www.lifetechnologies.com.
About Geospiza
Geospiza has redefined the genetic analysis software market with the only solution to help customers manage genetic analysis “From Sample to Results™”. Designed by biologists, Geospiza’s products are configured to reflect best practices and to work out-of-the-box, so that researchers can focus on their discoveries. Used by researchers, laboratories and core facilities in universities, government, biotechnology, and pharmaceutical companies, Geospiza’s software systems have established an international reputation for usability and performance since 1997. You can find more information on Geospiza and its products at www.geospiza.com.
